Effect of oral pyridoxine hydrochloride supplementation on arterial blood pressure in patients with essential hypertension
dc.contributor.author | Aybak, M | |
dc.contributor.author | Sermet, A | |
dc.contributor.author | Ayyildiz, MO | |
dc.contributor.author | Karakilcik, AZ | |
dc.date.accessioned | 2024-04-24T17:33:35Z | |
dc.date.available | 2024-04-24T17:33:35Z | |
dc.date.issued | 1995 | |
dc.department | Dicle Üniversitesi | en_US |
dc.description.abstract | The purpose of this study was to test the effect of vitamin B-6 (pyridoxine-HCl, CAS 58-56-0) supplementation on arterial blood pressure in essential hypertension. The trial comprised 9 normotensive subjects (7 men and 2 women, aged between 32-58 years, mean +/- SD, 48 +/- 11) and 20 patients with essential hypertension (16 men and 4 women, aged between 32-69 years, mean +/- SD, 56 +/- 12). The patients were treated during 4 weeks with a single oral dose of pyridoxine (5 mg/kg body weight/day). After a 5-min rest, measurements were made in the supine position. When compared with the normotensive subjects, the hypertensive subject group had a significantly higher systolic and diastolic blood pressure (p < 0.001) and higher level of plasma norepinephrine (E) (p < 0.01) before pyridoxine treatment. On the other hand there, were no significant differences in plasma epinephrine (E) and heart rates. Treatment of hypertensive patients with pyridoxine significantly reduced systolic (p < 0.01) and diastolic blood pressure (p < 0.005), plasma NE (p < 0.005) and E (p < 0.05) within 4 weeks. However, there was no significant difference in heart rate at the end of pyridoxine treatment. These results indicate a relationship between pyridoxine status and arterial blood pressure in the essential hypertensive patients. | en_US |
dc.identifier.endpage | 1273 | en_US |
dc.identifier.issn | 0004-4172 | |
dc.identifier.issue | 12 | en_US |
dc.identifier.pmid | 8595083 | |
dc.identifier.scopus | 2-s2.0-0029569067 | |
dc.identifier.scopusquality | N/A | |
dc.identifier.startpage | 1271 | en_US |
dc.identifier.uri | https://hdl.handle.net/11468/20762 | |
dc.identifier.volume | 45-2 | en_US |
dc.identifier.wos | WOS:A1995TN02000006 | |
dc.identifier.wosquality | N/A | |
dc.indekslendigikaynak | Web of Science | |
dc.indekslendigikaynak | Scopus | |
dc.indekslendigikaynak | PubMed | |
dc.language.iso | en | en_US |
dc.publisher | Ecv-Editio Cantor Verlag Medizin Naturwissenschaften | en_US |
dc.relation.ispartof | Arzneimittel-Forschung/Drug Research | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Cas 58-56-0 | en_US |
dc.subject | Hypertension, Essential | en_US |
dc.subject | Pyridoxine, Clinical Studies, Effects On Blood Pressure | en_US |
dc.subject | Vitamin B-6 | en_US |
dc.title | Effect of oral pyridoxine hydrochloride supplementation on arterial blood pressure in patients with essential hypertension | en_US |
dc.title | Effect of oral pyridoxine hydrochloride supplementation on arterial blood pressure in patients with essential hypertension | |
dc.type | Article | en_US |